Skip to content

Does who classify aging as a disease? The World Health Organization's position on aging

4 min read

In 2022, the World Health Organization (WHO) faced significant debate over its International Classification of Diseases (ICD-11) revisions concerning aging. As a result, the WHO does not classify aging as a disease, instead opting for a more nuanced approach focused on functional decline and healthy aging. This decision highlights a major point of contention within the medical and scientific community about how we define and address the universal process of getting older.

Quick Summary

The World Health Organization does not classify aging as a disease, opting for the term 'ageing-associated decline in intrinsic capacity' in its ICD-11. This decision reflects a complex debate and aims to prevent ageism, but it contrasts with some scientific and longevity research perspectives.

Key Points

  • WHO Does Not Classify Aging as a Disease: The World Health Organization (WHO) explicitly states that aging itself is not a disease in the ICD-11, opting for the more nuanced phrase, 'ageing-associated decline in intrinsic capacity'.

  • Term 'Ageing-related' Exists for Specific Conditions: The ICD-11 includes an extension code (XT9T) for "Ageing-related" that can be used to denote aging as a contributing factor or underlying cause for specific diseases, without labeling aging as a disease itself.

  • Concerns About Ageism Drove the Decision: A major reason for the WHO's stance was to prevent potential harm from ageism, where attributing health issues to 'old age' could lead to misdiagnosis or dismissive medical care for older patients.

  • Clash with Longevity Research Advocates: Some longevity scientists argue for classifying aging as a disease to unlock funding and expedite the development of treatments that target the fundamental biological mechanisms of aging.

  • Focus is on Functional Ability: The WHO's approach promotes 'healthy aging,' concentrating on maintaining a person's functional abilities and overall well-being as they get older, rather than seeking a 'cure' for the process.

  • Impact on Medical Practice: The current classification encourages clinicians to investigate specific symptoms and pathologies in older adults, rather than simply writing them off as a consequence of age.

In This Article

WHO's Official Stance: Aging Is Not a Disease

When considering the question, "Does WHO classify aging as a disease?", the definitive answer is no, not in the traditional sense. The World Health Organization (WHO), the authoritative body for the International Classification of Diseases (ICD), made a conscious decision in the development of ICD-11 not to categorize aging itself as a disease. This position was developed to address several concerns, including the potential for increased ageism, misuse of diagnosis, and the dismissal of specific health issues that can accompany aging.

Instead of listing 'old age' as a disease, the WHO adopted the term "ageing-associated decline in intrinsic capacity" (MG2A). This phrasing focuses on the physiological and functional changes that can happen with age, rather than medicalizing the entire human life process. The ICD-11 also includes an extension code (XT9T) for "Ageing-related" to be used in conjunction with specific diseases where aging is a significant risk factor. This nuanced approach allows for the tracking of age-related health issues without labeling the universal and natural process of aging itself as an illness.

The Historical Context: The Debate Over Classifying Aging

The debate surrounding the classification of aging has evolved considerably. Historically, the concept of aging as an inevitable, unchangeable process has dominated. However, advances in biogerontology have led some scientists and longevity advocates to argue that aging should be viewed as a treatable condition or disease. Their argument is that by classifying aging as a disease, greater research funding and more targeted interventions can be developed to extend healthspan and address age-related pathologies at their root cause.

In the lead-up to the ICD-11, the WHO had considered including 'old age' as a diagnostic term, replacing the outdated 'senility'. This proposal drew significant backlash from many in the medical community, particularly geriatricians, who feared it would have harmful consequences. The concerns included that doctors might use "old age" as a catch-all diagnosis, missing treatable conditions, and that it could reinforce discriminatory attitudes toward older people. The WHO ultimately withdrew the proposal and settled on its current, more descriptive terminology.

Contrasting Perspectives: WHO vs. Longevity Science

There is a fundamental difference in philosophy between the WHO's approach and that of some longevity researchers. The WHO focuses on promoting healthy aging and improving functional ability, viewing aging as a natural process with associated health issues that require management rather than a cure. In contrast, some longevity advocates see aging as a medical target with underlying biological mechanisms that can be actively intervened upon.

Comparison of Approaches to Aging

Aspect World Health Organization (WHO) Approach Longevity Science/Advocate Approach
Core Philosophy Views aging as a natural life process. Focus is on 'healthy aging,' maximizing functional ability and well-being. Views aging as a treatable pathological process or disease. Goal is to intervene in the underlying mechanisms to extend healthspan and potentially lifespan.
Terminology Uses terms like "ageing-associated decline in intrinsic capacity" (MG2A) and an extension code for "Ageing-related" (XT9T) in ICD-11. Uses disease-oriented language, arguing that aging fits the medical definition of a disease due to its harmful impact on function.
Risk of Ageism High concern that classifying aging as a disease would validate and increase ageism in society and healthcare. Views the acceptance of aging as a 'normal' decline as a form of ageism itself.
Funding for Research Supports research for age-related conditions but is not structured to specifically fund 'curing aging' itself. Believes classifying aging as a disease would unlock vast amounts of research funding for therapies targeting the biological roots of aging.
Medical Practice Encourages holistic, person-centered care for older adults, focusing on managing complex, multiple conditions rather than a single 'aging disease'. Proposes a paradigm shift toward preventative medicine that addresses the fundamental mechanisms of aging before diseases manifest.

The Clinical and Social Implications

The way aging is categorized has real-world consequences for healthcare systems, research, and individuals. For clinicians and medical practitioners, the WHO's stance ensures that symptoms are not simply attributed to 'old age,' prompting a thorough investigation for underlying, treatable conditions. This promotes better diagnostic practices and prevents missed opportunities for effective treatment.

From a societal standpoint, the WHO's position is a crucial part of combating ageism. By reframing the conversation around healthy aging and intrinsic capacity, it challenges the stereotype that older people are inherently frail and dependent. This encourages a focus on resilience and overall well-being, emphasizing that health is not defined by chronological age.

Conversely, supporters of the disease classification argue that the current system is financially and functionally unsustainable. They point out that a significant portion of healthcare spending goes toward managing chronic diseases in the last years of life, which they argue could be prevented by targeting the underlying aging process earlier. This viewpoint envisions a future where interventions could significantly compress morbidity, extending the period of healthy life.

Conclusion

The World Health Organization has clearly stated its position: it does not classify aging as a disease in its International Classification of Diseases (ICD-11). Instead, it advocates for a holistic, functional approach focused on "healthy aging" and managing "ageing-associated decline in intrinsic capacity". This decision was made to combat ageism and prevent the misattribution of specific health issues to the natural process of getting older. While this perspective clashes with that of some longevity researchers who believe treating aging as a disease would accelerate therapies, the WHO's framework provides a practical and ethical guideline for medical care today. The ongoing debate highlights the complex intersection of biology, medicine, ethics, and social policy in how humanity grapples with its own finitude.

Frequently Asked Questions

In the ICD-11, the official term for the functional changes associated with getting older is "ageing-associated decline in intrinsic capacity" (MG2A).

The WHO's decision was motivated by concerns over promoting ageism and the risk of poor medical care. Labeling aging a disease could lead doctors to improperly diagnose serious, treatable conditions as simply "old age," reinforcing negative stereotypes.

Yes, the ICD-11 includes an extension code (XT9T) for "Ageing-related." This code is used to indicate that aging is an underlying risk factor for a specific disease or condition, allowing for better data collection.

No, a vocal group of longevity scientists and researchers disagrees with the WHO. They argue that aging fits the medical definition of a disease and that classifying it as such would lead to increased research funding for interventions that target the aging process itself.

The WHO's approach aligns with modern geriatric medicine, which focuses on person-centered care. This model encourages addressing individual health issues and promoting functional ability and resilience, rather than treating age as a single, overarching problem.

The WHO promotes 'healthy aging' to maximize well-being, while the 'anti-aging' or longevity science view seeks to intervene and potentially stop the biological processes of aging, often framing it as a disease to be cured.

Similar to the WHO, the U.S. Food and Drug Administration (FDA) views aging as a natural process, not a disease. This makes it challenging to get approval for drugs that target aging directly; instead, treatments must target specific age-related diseases.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice. Always consult a qualified healthcare provider regarding personal health decisions.